Recombinant VEGF (Bevacizumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all VEGF (Bevacizumab Biosimilar) products
- VEGF (Bevacizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Bevacizumab Biosimilar - Anti-VEGF mAb
- Characteristics
- Antibody Type: IgG1
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1, IgG1 kappa
-
anti-VEGF (Bevacizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer pH 7.5
- Storage
- 4 °C,-20 °C
- Storage Comment
- 4°C for short term, -20°C for long term
-
- Target
- VEGF (Bevacizumab Biosimilar)
- Abstract
- VEGF (Bevacizumab Biosimilar) Products
- Synonyms
- MVCD1 antibody, VEGF antibody, VPF antibody, vascular endothelial growth factor A antibody, VEGFA antibody
- Target Type
- Biosimilar
- Background
- Bevacizumab
-
You are here:
